By Matt Grossman
Boston Scientific Corp. on Tuesday returned to a profit in the second quarter, as sales recovered amid higher healthcare demand as the coronavirus pandemic eased.
The Marlborough, Mass.-based medical-devices maker logged earnings of 12 cents a share, compared with a loss of 11 cents a share a year earlier. Total net income was $186 million, compared with a net loss of $147 million.
Stripping out one-time items, the company's adjusted earnings were 40 cents a share. Analysts polled by FactSet were forecasting adjusted earnings of 37 cents a share.
Sales rose to $3.08 billion from $2 billion a year earlier, the company said. Analysts had been anticipating sales of $2.94 billion.
Medical-surgical sales rose 65% to $948 million. Rhythm and neuro sales were up 65% at $866 million. Cardiovascular sales improved by 51% to $1.26 billion, the company said.
Write to Matt Grossman at firstname.lastname@example.org
(END) Dow Jones Newswires
July 27, 2021 07:02 ET (11:02 GMT)Copyright (c) 2021 Dow Jones & Company, Inc.